Investment ThemesDetailed Quotes
Cancer Research
Watchlist
Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
- 1145.971
- +1.879+0.16%
Close Mar 27 16:00 ET
1151.789High1143.402Low
1148.854Open1144.092Pre Close84.42MVolume4Rise30.57P/E (Static)4.11BTurnover--Flatline0.61%Turnover Ratio875.83BMarket Cap5Fall864.40BFloat Cap
Constituent Stocks: 9Top Rising: GILD+1.73%
Sign in to post a comment
$Pfizer (PFE.US)$
Added some shares at 24.93 to DCA.
Added some shares at 24.93 to DCA.
3
$Merck & Co (MRK.US)$ if Merck can"t look for a drug replacement by 2028 the share is going to get screw so perhaps this is part of the risk
$Pfizer (PFE.US)$
The stock price has fallen outside the lower band. It should rebound back to lower band soon at 25.16. Waiting for hammer to appear.
The stock price has fallen outside the lower band. It should rebound back to lower band soon at 25.16. Waiting for hammer to appear.
2
$Pfizer (PFE.US)$
Added some shares at 25.12 and 25.09 to DCA.
Added some shares at 25.12 and 25.09 to DCA.
5
$Pfizer (PFE.US)$ bottomed yet?
$Pfizer (PFE.US)$
Donald Trump’s justice department is investigating claims that Pfizer delayed positive news about its Covid-19 vaccine until after the 2020 election.
Pfizer said it had not been contacted about the investigation and called the claims “utter nonsense”.
“We cannot comment because we have not received any inquiry from authorities about a so-called ‘delay,’ but Pfizer remains ready, willing, and able to explain why any allegation of impropriety is utter nonsense,” a spokesman said.
...
Donald Trump’s justice department is investigating claims that Pfizer delayed positive news about its Covid-19 vaccine until after the 2020 election.
Pfizer said it had not been contacted about the investigation and called the claims “utter nonsense”.
“We cannot comment because we have not received any inquiry from authorities about a so-called ‘delay,’ but Pfizer remains ready, willing, and able to explain why any allegation of impropriety is utter nonsense,” a spokesman said.
...
$Pfizer (PFE.US)$ Stand up
1
3
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Never give up. Long on this stock for dividend.
$Pfizer (PFE.US)$
ok i am in
ok i am in
1
2
I guess whoever is behind this didn't get the results they wanted. PFE only drops by about 29 cents. ![]()
![]()
![]()
![]()
Shorting over 100M, you better have something more than this. You are going to get the mother of all squeeze (MOAS)!
$Pfizer (PFE.US)$ $SPDR S&P 500 ETF (SPY.US)$
Shorting over 100M, you better have something more than this. You are going to get the mother of all squeeze (MOAS)!
$Pfizer (PFE.US)$ $SPDR S&P 500 ETF (SPY.US)$
2
1
1
$Pfizer (PFE.US)$
Added some shares at 25.39 to DCA.
Added some shares at 25.39 to DCA.
1
2
No comment yet
Mr Value investor : why it is keep falling any idea?
Deep Sea OP Mr Value investor : could be due to below news:
The U.S. is planning to end its financial support for Gavi, a WHO-backed organization that aims to ensure equitable access to vaccines worldwide, The New York Times reported Wednesday, citing a memo the Trump administration sent to Congress.
Mr Value investor : i see. thanks!